Clinical Trial Update: SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SCH 66336 in children with recurrent or progressive brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor

Drugs mentioned

• SCH 66336 (lonafarnib)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED